Wende Kristian, Bruno Giuliana, Lalk Michael, Weltmann Klaus-Dieter, von Woedtke Thomas, Bekeschus Sander, Lackmann Jan-Wilm
ZIK Plasmatis, Leibniz Institute for Plasma Science and Technology (INP Greifswald) Felix-Hausdorff-Str. 2 Greifswald 17489 Germany
Cellular Biochemistry & Metabolomics, University of Greifswald Felix-Hausdorff-Str. 4 Greifswald 17487 Germany.
RSC Adv. 2020 Mar 17;10(20):11598-11607. doi: 10.1039/c9ra08745a. eCollection 2020 Mar 19.
Cold atmospheric plasmas (CAPs) are promising medical tools and are currently applied in dermatology and epithelial cancers. While understanding of the biomedical effects is already substantial, knowledge on the contribution of individual ROS and RNS and the mode of activation of biochemical pathways is insufficient. Especially the formation and transport of short-lived reactive species in liquids remain elusive, a situation shared with other approaches involving redox processes such as photodynamic therapy. Here, the contribution of plasma-generated reactive oxygen species (ROS) in plasma liquid chemistry was determined by labeling these admixing heavy oxygen O to the feed gas or by using heavy water H O as a solvent for the bait molecule. The inclusion of heavy or light oxygen atoms by the labeled ROS into the different cysteine products was determined by mass spectrometry. While products like cysteine sulfonic acid incorporated nearly exclusively gas phase-derived oxygen species (atomic oxygen and/or singlet oxygen), a significant contribution of liquid phase-derived species (OH radicals) was observed for cysteine--sulfonate. The role, origin, and reaction mechanisms of short-lived species, namely hydroxyl radicals, singlet oxygen, and atomic oxygen, are discussed. Interactions of these species both with the target cysteine molecule as well as the interphase and the liquid bulk are taken into consideration to shed light onto several reaction pathways resulting in observed isotopic oxygen incorporation. These studies give valuable insight into underlying plasma-liquid interaction processes and are a first step to understand these interaction processes between the gas and liquid phase on a molecular level.
冷大气等离子体(CAPs)是很有前景的医学工具,目前已应用于皮肤科和上皮癌治疗。虽然对其生物医学效应已有大量了解,但关于单个活性氧(ROS)和活性氮(RNS)的作用以及生化途径的激活模式的知识仍不足。特别是液体中短寿命活性物种的形成和传输仍然难以捉摸,这与其他涉及氧化还原过程的方法(如光动力疗法)情况相同。在此,通过向进料气体中添加重氧O标记等离子体产生的活性氧(ROS),或使用重水H O作为诱饵分子的溶剂,来确定血浆液体化学中血浆产生的活性氧的作用。通过质谱法确定标记的ROS将重或轻氧原子纳入不同半胱氨酸产物的情况。虽然像半胱氨酸磺酸这样的产物几乎只包含气相衍生的氧物种(原子氧和/或单线态氧),但对于半胱氨酸 - 磺酸盐,观察到液相衍生物种(OH自由基)有显著贡献。讨论了短寿命物种,即羟基自由基、单线态氧和原子氧的作用、来源和反应机制。考虑了这些物种与目标半胱氨酸分子以及相间和液体主体的相互作用,以阐明导致观察到的同位素氧掺入的几种反应途径。这些研究为潜在的等离子体 - 液体相互作用过程提供了有价值的见解,是在分子水平上理解气 - 液相间这些相互作用过程的第一步。